Fresenius Kabi has begun selling gadoterate meglumine injection, USP, a bioequivalent and therapeutic equivalent substitute for Guerbet’s contrast agent Dotarem. The product launch is the second contrast agent Fresenius Kabi has introduced in the U.S. this year. The Kale Zurich, Illinois–based company launched iodixanol injection, USP, in July during a nationwide shortage. Radiologists use contrast agents…

Fresenius Kabi has announced a three-year plan to add GS1 Data Matrix barcodes to its pharmaceutical portfolio.  GS1 Data Matrix barcodes are also known as 2D barcodes.  The company manufactures a range of vials, syringes, IV products and parenteral nutrition products.   The Lake Zurich, Illinois–based company says the decision will reduce the need for manual data entry…

Fresenius Kabi announced today that its portfolio of radio frequency tagged medications is now compatible with an AmerisourceBergen offering. Lake Zurich, Illinois-based Fresenius Kabi’s growing +RFID portfolio now has compatibility with AmerisourceBergen’s medication tray solution for helping hospitals improve medication inventory visibility and tracking using advanced radiofrequency identification (RFID) technology. According to a news release,…